Enable personalized
symptom management

Theraxium Oncology provides actionable answers,
whenever patients and care teams need them,
to enhance care and collaboration.

Watch the video

Key Product Features

Our digital therapeutic moves mountains

Theraxium Oncology helps empower patients to self-manage their symptoms. Our technology combines a prescription app for patients with a web app for health care teams.

  • Patients report symptom data in the smartphone app to receive immediate actionable recommendations that are personalized to their profile and current condition.
  • Care teams can follow the progress of their entire patient population from their desks thanks to their web app, no download needed.

The clinical algorithms that back our technology are consistent with both US and EU guidelines for symptom management in oncology.  They help care teams provide support to patients wherever they are, whenever they need it. A few small clicks take symptom management further than ever before.

Care companion for the patient journey

Theraxium Oncology awaits in patients’ pockets, ready to provide answers whenever they need them. Whether they’re starting a new treatment or already in therapy, experiencing symptoms such as fever or high blood pressure, patients receive personalized insights to manage their issues. Recommendations are made in accordance with the treatment plan set up by their care team. Leveraging embedded clinical algorithms, the application can help patients:

  • Identify, qualify and report their symptoms
  • Take action to self-manage their symptoms
  • Know when they need to contact their care team
  • Gain knowledge about their disease

Theraxium Oncology aims to improve quality of life, treatment adherence and collaboration with care teams while lowering costs.

Compass for care team decision-making

Know what you need to, when you need to, so you can make the most informed decision. Theraxium Oncology creates reports and analyzes how patients are living with their symptoms in real time, so that care teams have the power to:

  • Triage patients to know who needs the most attention
  • Take action to modify the treatment plan or follow up with the patient
  • Coordinate better with all care team members

Care teams can better anticipate and implement responsive care strategies that work to serve each patient’s individual needs when they need it most. They can also optimize their time by spending more of it with patients who need assistance and talking with patients during their appointments rather than collecting data.

Our Cancer Care Clinician Experts

We’ve called on some of the leading minds in cancer care to help us design the clinical principles underlying our digital therapeutics. They’re the members of our clinical advisory board, which gathers experts from preeminent institutions in cancer treatment all over the United States and Europe.

The Expertise Behind Our Technology

Proven track record

Over the past three years, we’ve continuously incorporated feedback from leading cancer care centers, patients and care teams to create a system that not only works with existing clinical workflows but also meets user satisfaction.

Robust platform

Our Theraxium platform is the backbone for all our oncology solutions, providing a robust infrastructure and rapid deployment for each digital therapeutic we create. The 50 solutions it has deployed have managed over 600,000 patients in 10 countries.

Expert teams

Voluntis is more than a technology innovator. With in-house clinical affairs, regulatory, market access and real-world evidence specialists, our teams carry digital therapeutics from clinical design to market launch to patient support.

Our Pipeline for the Cancer Care Ecosystem

Theraxium has been used as the backbone for a pipeline of oncology digital therapeutics

Treatment Type
Program
Prototype
Development
Regulatory Meetings
Product Validation
Clearance
Targeted therapy
TxO-VEGF
Targeted therapy
TxO-CDK
Targeted therapy
TxO-BRAF/MEK
Immuno-oncology
TxO-I/O
Chemotherapy
TxO-Chemo
Targeted therapy
TxO-EGFR
Targeted therapy
TxO-BTK/CBL2

Our Partners in innovating Cancer Care

AstraZeneca selected Theraxium Oncology to design a digital therapeutic that supports women undergoing treatment for ovarian cancer.

Roche leverages the Theraxium solution to create a digital therapeutic for women with breast cancer to manage their most frequent symptoms.

What We’re Up To

Ready to talk?

Do you share our desire to improve symptom management in oncology? Tell us about it!

An answer is required for each field marked with an (*)